Tuvia Gilat
Directeur Technique/Scientifique/R&D chez Galmed Medical Research Ltd.
Profil
Tuvia Gilat is the founder of Galmed Pharmaceuticals Ltd.
which was founded in 2000.
Currently, he is the Scientific Director at Galmed Medical Research Ltd.
Dr. Gilat's former positions include Director at BioCancell Therapeutics, Inc. and Director at Tel-Aviv Sourasky Medical Center where he served as Director from 1965 to 1996.
Dr. Gilat holds a doctorate degree from The Hebrew University of Jerusalem.
Postes actifs de Tuvia Gilat
| Sociétés | Poste | Début |
|---|---|---|
| Galmed Medical Research Ltd. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Tuvia Gilat
| Sociétés | Poste | Fin |
|---|---|---|
Tel-Aviv Sourasky Medical Center
 Tel-Aviv Sourasky Medical Center Hospital/Nursing ManagementHealth Services Tel-Aviv Sourasky Medical Center operates as a medical center. Tel Aviv Sourasky Medical Center provides progressive full-service healthcare treatment and research institutions in Israel. The Medical Center draws patients from throughout the world for specialty care and routine procedures through the medical tourism program, designed specifically for the needs of international patients. The center was founded in 1963 and is headquartered in Tel Aviv, Israel. | Directeur/Membre du Conseil | 01/01/1996 |
| GALMED PHARMACEUTICALS LTD. | Fondateur | - |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Directeur/Membre du Conseil | - |
Formation de Tuvia Gilat
| The Hebrew University of Jerusalem | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GALMED PHARMACEUTICALS LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
Tel-Aviv Sourasky Medical Center
Tel-Aviv Sourasky Medical Center Hospital/Nursing ManagementHealth Services Tel-Aviv Sourasky Medical Center operates as a medical center. Tel Aviv Sourasky Medical Center provides progressive full-service healthcare treatment and research institutions in Israel. The Medical Center draws patients from throughout the world for specialty care and routine procedures through the medical tourism program, designed specifically for the needs of international patients. The center was founded in 1963 and is headquartered in Tel Aviv, Israel. | Health Services |
| Galmed Medical Research Ltd. |
